lapachol has been researched along with Leishmaniasis, Visceral in 1 studies
lapachol : A hydroxy-1,4-naphthoquinone that is 1,4-naphthoquinone substituted by hydroxy and 3-methylbut-2-en-1-yl groups at positions 2 and 3, respectively. It is a natural compound that exhibits antibacterial and anticancer properties, first isolated in 1882 from the bark of Tabebuia avellanedae.
Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araújo, IAC | 1 |
| de Paula, RC | 1 |
| Alves, CL | 1 |
| Faria, KF | 1 |
| Oliveira, MM | 1 |
| Mendes, GG | 1 |
| Dias, EMFA | 1 |
| Ribeiro, RR | 1 |
| Oliveira, AB | 1 |
| Silva, SMD | 1 |
1 other study available for lapachol and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Disease Models, Animal; Female; Flow Cytometry; Hep G | 2019 |